BIOMAT Database Logo BIOMAT Database Logo

Differential expression of two ICAM-1 epitopes and LFA-1 chains in B-cell non-Hodgkin's lymphomas. 1994

A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Italy.

B-cell non-Hodgkin's lymphomas (B-NHL) and B-cell areas of reactive lymphadenopathies were investigated immunohistochemically for expression of two distinct ICAM-1 epitopes, Me14/D12 and P3-58, and the LFA-1 alpha and beta chains. Partial or total loss of expression of one or both epitope(s) and/or chain(s) was evident in all B-NHL in function of increasing Working Formulation (WF) malignancy grade, with most defects in the high-grade tumors, namely the lowest detectability of the ICAM-1 Me14/D12 and LFA-1 alpha chain, the lowest co-expression of ICAM-1 epitopes and LFA-1 chains, and the most frequent simultaneous loss. The ICAM-1 and LFA-1 profiles overlapped within the low- and intermediate-grades, whereas striking differences between the high-grade subtypes were detected. Specifically, Burkitt's and lymphoblastic tumors always lost both epitopes and both chains. Large cell, immunoblastic tumors occasionally did so, and also showed either uncoordinated expression or co-expression of these constituents. It is suggested that expression defects of this type may help differentiate malignant from benign lymphoproliferations, and also be involved in the progression of B-NHL, since most are observed in high-grade tumors, whose ICAM-1 and LFA-1 profiles indicate that their subtypes are the expression of distinct normal B-cell differentiation stages.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D015815 Cell Adhesion Molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. Cell Adhesion Molecule,Intercellular Adhesion Molecule,Intercellular Adhesion Molecules,Leukocyte Adhesion Molecule,Leukocyte Adhesion Molecules,Saccharide-Mediated Cell Adhesion Molecules,Saccharide Mediated Cell Adhesion Molecules,Adhesion Molecule, Cell,Adhesion Molecule, Intercellular,Adhesion Molecule, Leukocyte,Adhesion Molecules, Cell,Adhesion Molecules, Intercellular,Adhesion Molecules, Leukocyte,Molecule, Cell Adhesion,Molecule, Intercellular Adhesion,Molecule, Leukocyte Adhesion,Molecules, Cell Adhesion,Molecules, Intercellular Adhesion,Molecules, Leukocyte Adhesion
D016169 Lymphocyte Function-Associated Antigen-1 An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1. LFA-1,Leukocyte Function Associated Antigen-1,Integrin alphaLbeta2,Antigen-1, Lymphocyte Function-Associated,Lymphocyte Function Associated Antigen 1,alphaLbeta2, Integrin

Related Publications

A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
MCL-1 expression in B-cell non-Hodgkin's lymphomas.
September 2004, Human pathology,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Expression of leukocyte adhesion molecules (ICAM-1/LFA-1) related to clinical behaviour in B cell lymphomas.
January 1992, Hematological oncology,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
CD8 expression in B-cell non-Hodgkin's lymphomas.
July 2008, Annals of hematology,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Expression of adhesion molecules LFA-1, ICAM-1, CD44, and L-selectin in childhood non-Hodgkin lymphomas.
March 2001, Medical and pediatric oncology,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
B-cell homotypic adhesion through exon-A restricted epitopes of CD45 involves LFA-1/ICAM-1, ICAM-3 interactions, and induces coclustering of CD45 and LFA-1.
September 1995, Blood,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia.
October 1988, Blood,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation.
May 1998, Journal of immunology (Baltimore, Md. : 1950),
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Expression of LFA-1 in non-Hodgkin's lymphoma.
January 1989, Cancer,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines.
May 1993, International journal of cancer,
A Vacca, and G Ranieri, and D Ribatti, and R Di Stefano, and D Caloro, and G Serio, and M Di Loreto, and F Silvestris, and F Dammacco
Differential regulation of LFA-1 and ICAM-1 on human primary B-lymphocytes.
March 1993, Cellular immunology,
Copied contents to your clipboard!